INTERNATIONAL PATENT: DICOT PHARMA AB FILES APPLICATION FOR "PHRAGMALIN-DERIVED COMPOUNDS FOR USE IN THE TREATMENT AND/OR PREVENTION OF A METABOLIC DISEASE AND/OR DISORDER"

GENEVA, Dec. 15 -- DICOT PHARMA AB (St Olofsgatan 11A753 21 Uppsala) filed a patent application (PCT/EP2025/065820) for "PHRAGMALIN-DERIVED COMPOUNDS FOR USE IN THE TREATMENT AND/OR PREVENTION OF A METABOLIC DISEASE AND/OR DISORDER" on Jun 06, 2025. With publication no. WO/2025/252965, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GAUFFIN, Charlotta (Finnsta Rosenlund 14755 77 Vange), GILLBERG, Per-Goran (Vissboda 232694 96 Asbro)

Abstract: The disclosure provides a compound of Formula (I), or a stereoisomer or hydrate...